Aptar Pharma India Private Limited, based in Thane, Maharashtra, is the Indian subsidiary of AptarGroup Inc., a global leader in consumer dispensing packaging and drug delivery systems. With over 75 years of innovation and a strong international footprint, Aptar Pharma develops cutting-edge drug delivery devices and pharma-grade packaging solutions that improve patient adherence and therapeutic outcomes across multiple treatment areas.
Core Business
Aptar Pharma India focuses on:
- Advanced Drug Delivery Devices
- Pharmaceutical Dispensing Systems
- Component Manufacturing for Injectables and Inhalables
- Active Packaging Technologies
The company provides tailored, regulatory-compliant solutions for pharmaceutical, biotech, and consumer health sectors.
Product and Service Offerings
1. Drug Delivery Devices
- Nasal Spray Systems (for allergic rhinitis, nasal decongestion)
- Metered-Dose Inhaler (MDI) Valves
- Unidose and Bidose Systems for emergency and chronic therapies
- Dermal Delivery Systems (creams, gels, topical formulations)
2. Packaging Solutions
- Dispensing Closures for pharmaceutical liquids and semi-solids
- Elastomer Components used in autoinjectors and syringes
- Active Packaging Components (moisture control, oxygen scavengers)
3. Pharmaceutical Applications
- Nasal Saline & Decongestant Delivery
- Gastrointestinal and Digestive Disorder Treatments
- Cough & Cold Formulations
- Pain Management and Analgesic Devices
- Wound Healing and First Aid Solutions
- Ear and Eye Care Systems
These systems are designed to ensure dose accuracy, patient safety, and ease of administration, especially for chronic therapies and self-medication.
Specialization and Core USP
Aptar Pharma is globally recognized for:
- End-to-end device development from concept to industrial scale-up
- Regulatory expertise with FDA, EMA, and ANVISA compliant solutions
- Connected devices for digital health and medication tracking
- Proven track record of over 8 billion drug delivery systems sold annually
The company leverages deep scientific and engineering capabilities to support formulation-device compatibility and clinical trial support.
Financials
As a division of AptarGroup Inc.:
- Parent company reported annual revenues of USD 3.3 billion+
- Pharma segment contributes significantly, with India emerging as a regional innovation and supply hub
- Serving more than 200 pharmaceutical companies globally
Shipment Data
- Active supply of drug delivery components to Europe, North America, and APAC
- Devices and packaging materials exported in regulated and unregulated markets
- Key export items: Nasal sprays, inhaler valves, eye dropper components, unidose systems
Target Market
Aptar Pharma India targets:
- Global and Indian Pharmaceutical Manufacturers
- Biotech and Generic Drug Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- OTC Consumer Health Brands
Their customer base spans prescription drugs, specialty therapies, and personal care products.
Capabilities
- R&D Facilities: In-house labs for formulation testing and packaging compatibility
- Manufacturing Excellence: Cleanroom environments, ISO 13485-certified
- Design and Engineering: Custom mold development and industrial scalability
- Regulatory Support: Full technical documentation and validation services
Certifications and Compliance
- ISO 13485, ISO 15378, and ISO 9001-certified facilities
- Adheres to cGMP, FDA 21 CFR Part 820, and EU Annex 1 standards
- Regulatory support for US FDA, EU EMA, and Brazil ANVISA submissions
Customer Testimonials
“Aptar’s nasal spray system helped us fast-track regulatory approval and improve patient usage compliance.”
– Director, Global Formulation Development, Indian Pharma MNC
“We integrated their unidose system into our emergency migraine therapy, and it’s now a key differentiator in our product offering.”
– Brand Manager, US-based Pharma Company
Major Achievements
- Successfully launched over 1,000 SKUs of drug delivery devices globally
- Supported 30+ FDA/EMA drug-device combination approvals
- Developed digitally connected devices for adherence tracking in asthma and CNS therapies
- Established India as a strategic supply base for the APAC region
Aptar Pharma India continues to pioneer innovations in patient-centric drug delivery, combining robust engineering with world-class regulatory expertise to bring safer, smarter, and more effective health solutions to market.
